OOIR: Observatory of International Research

Papers

(The TQCC of Gut is 18. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-11-01 to 2025-11-01.)

Article	Citations
Defining the key intrahepatic gene networks in HCV infection driven by sex	1697
Picking up microbial clues in early-onset colorectal cancer	1455
Hepatocyte senescence in alcohol-associated hepatitis: epiphenomenon or disease-driving mechanism?	966
Correction:P97 A patient information bundle outlining dietary advice in liver disease specific to the cost of living crisis improves patient care: ‘Looking after Your Liver for Less’	460
Immunomodulation and entry inhibition: selgantolimod’s double punch against hepatitis B virus	329
S100A10 promotes HCC development and progression via transfer in extracellular vesicles and regulating their protein cargos	321
Establishment of enterically transmitted hepatitis virus animal models using lipid nanoparticle-based full-length viral genome RNA delivery system	222
Third Asia-Pacific consensus recommendations on colorectal cancer screening and postpolypectomy surveillance	220
Current therapies and new developments in NASH	203
Unusual history of ‘stitch’	202
Finding a mate for MLCK: improving the potential for therapeutic targeting of gut permeability	200
Response to McAlindon’s letter	200
Innumerable nodules in all parts of the small intestine	198
Growth rates and histopathological outcomes of small (6–9 mm) colorectal polyps based on CT colonography surveillance and endoscopic removal	188
Crohn’s disease and ulcerative colitis exhibit prediagnostic antibody signatures with shared and divergent changes towards disease onset	180
Perturbation of mRNA splicing in liver cancer: insights, opportunities and challenges	178
IL-3 receptor signalling suppresses chronic intestinal inflammation by controlling mechanobiology and tissue egress of regulatory T cells	171
HBcrAg values may predict virological and immunological responses to pegIFN-a in NUC-suppressed HBeAg-negative chronic hepatitis B	170
Impact of margin thermal ablation after endoscopic mucosal resection of large (≥20 mm) non-pedunculated colonic polyps on long-term recurrence	169
Genetically proxied ketohexokinase function and risk of colorectal cancer: a Mendelian randomisation study	168
Holistic healthcare in inflammatory bowel disease: time for patient-centric approaches?	164
Reassessing the prophylactic effect of clip closure to prevent delayed rebleeding after colorectal endoscopic submucosal dissection	162
Gut virome-colonisingOrthohepadnavirusgenus is associated with ulcerative colitis pathogenesis and induces intestinal inflammationin vivo	161
A mucus production programme promotes classical pancreatic ductal adenocarcinoma	151
Liquid biopsy to identify Barrett’s oesophagus, dysplasia and oesophageal adenocarcinoma: theEMERALDmulticentre study	151

Absence of a pancreatic microbiome in intraductal papillary mucinous neoplasm	150
COVID-19 and liver disease	149
Autologous regulatory T-cell transfer in refractory ulcerative colitis with concomitant primary sclerosing cholangitis	148
Rate of suitable cases for primary EUS-guided biliary drainage in distal malignant biliary obstruction	146
Mass cytometry-based peripheral blood analysis as a novel tool for early detection of solid tumours: a multicentre study	143
Where are we with gastric cancer screening in Europe in 2024?	139
Methionine deficiency facilitates antitumour immunity by altering m⁶A methylation of immune checkpoint transcripts	137
Definite benefits of GLP-1 receptor agonists: what is the risk of gastroparesis and lung aspiration?	134
Perplexing case of abdominal pain with eosinophilia and fasciitis	131
Selective decontamination of the digestive tract in critically ill children: fighting fire with fire or burning down the house?	130
Association between appendectomy and Parkinson’s disease from the UK Biobank	126
Interactive enhancer hubs (iHUBs) mediate transcriptional reprogramming and adaptive resistance in pancreatic cancer	121
Correction: Inflammatory cell-derived CXCL3 promotes pancreatic cancer metastasis through a novel myofibroblast-hijacked cancer escape mechanism	115
Time for arginine methylation: PRMT5 inhibition to advance cholangiocarcinoma treatment	115
Endoscopic mucosal and submucosal cutting for long benign oesophageal strictures	114
Rare cause of obstructive jaundice	114
GI highlights from the literature	113
Tiny contributors to severe obesity inside the gut	110
Shaggy white lesion with morphological changes in the oesophagus	108
Lumen-apposing metal stents versus double-pigtail plastic stents for infected necrotising pancreatitis: more doubts than answers	107
Discovery of the pancreatic basal cell: a new candidate for an adult stem cell emerges	105
Most excess years of potential life loss among individuals with cirrhosis during the pandemic were not related to COVID-19	105
Unveiling 8 years of duodenoscope contamination: insights from a retrospective analysis in a large tertiary care hospital	105
Tumour-intrinsic alterations and stromal matrix remodelling promote Wnt-niche independence during diffuse-type gastric cancer progression	103
Faecal occult blood loss accurately predicts future detection of colorectal cancer. A prognostic model	103
Engineered anti-PDL1 with IFNα targets both immunoinhibitory and activating signals in the liver to break HBV immune tolerance	102
Asian Pacific Association of Gastroenterology task force recommendations on surveillance for Helicobacter pylori associated gastric premalignant conditio	102
New entity of adult ultra-short coeliac disease: the first international cohort and case–control study	102
Host transcriptome signatures in human faecal-washes predict histological remission in patients with IBD	101
Hypothesis-generating evaluation of multi-armoured oncolytic HSV-1 (VG161) in intrahepatic cholangiocarcinoma: pooled insights from multicentre studies	101
Impact of climate change on vulnerable populations	100
24-Nor-ursodeoxycholic acid improves intestinal inflammation by targeting T_H17 pathogenicity and transdifferentiation	99
Humoral response to SARS-CoV-2 infection among liver transplant recipients	98
Intron-mediated enhancement of SPINK1 expression for pancreatitis therapy	97
Reflux conditions induce E-cadherin cleavage and EMT via APE1 redox function in oesophageal adenocarcinoma	96
Large-scale multiomic analysis identifies non-coding somatic driver mutations and nominates ZFP36L2 as a driver gene for pancreatic ductal adenocarcinoma	95
Gastrointestinal microbiota and inflammasomes interplay in health and disease: a gut feeling	94
Need for standardised approaches to human microbiome research using the example of colorectal neoplasia research	91
MicroRNA-223 attenuates hepatocarcinogenesis by blocking hypoxia-driven angiogenesis and immunosuppression	91
British Society of Gastroenterology guidelines on sedation in gastrointestinal endoscopy	89
Integrated multimodel analysis of intestinal inflammation exposes key molecular features of preclinical and clinical IBD	87
Targeting hepatic stellate cells to combat liver fibrosis: where do we stand?	85
Extracellular Vesicles from Pancreatic Cancer Stem Cells Lead an Intratumor Communication Network (EVNet) to fuel tumour progression	85
Withdrawal of the British Society of Gastroenterology IBD risk grid for COVID-19 severity	83
Association between inflammatory bowel disease and Alzheimer’s disease: multivariable and bidirectional Mendelian randomisation analyses	81
Endoscopic stratification of gastric intestinal metaplasia: where are we, where do we want to go and how do we get there?	81
SARS-CoV-2 vaccination in patients with GI and hepatobiliary carcinoma: a call for booster vaccination	81
Treatment of type 2 diabetes with MASLD: new evidence for personalised medicine	80
Reply: Prevalence of serum HBsAg <100 IU/mL in inactive chronic hepatitis B	79
Environmental and healthcare trade-offs between single-use and reusable gastroscopes	79

GI highlights from the literature	76
SMYD2-mediated methylation of STAT1 protects against hepatic ischaemia/reperfusion injury by blocking JAK-STAT1 signalling pathways	76
Ebastine for the treatment of irritable bowel syndrome: old drug, new tricks?	74
Correction: Prevalence of irritable bowel syndrome and functional dyspepsia after acute gastroenteritis: systematic review and meta-analysis	74
APCmosaicism, not always isolated: two first-degree relatives with apparently distinctAPCmosaicism	73
Anticoagulation in colorectal ESD: implications for bleeding risk management	72
Rethinking routine mapping biopsies in gastric intestinal metaplasia: justification for endoscopic stratification	71
Endoscopic papillectomy versus surgical ampullectomy for adenomas and early cancers of the papilla: a retrospective Pancreas2000/European Pancreatic Club analysis	71
Correction: Revisiting the role of sphincterotomy in sphincter of oddi disorder: a critical appraisal of the RESPOnD study	71
Fasting-mimicking diet-enriched Bifidobacterium pseudolongum suppresses colorectal cancer by inducing memory CD8⁺ T cells	71
British Society of Gastroenterology interim framework for addressing the COVID-19-related backlog in inflammatory bowel disease colorectal cancer surveillance	68
Impact of age, comorbidities and relevant changes on surveillance strategy of intraductal papillary mucinous neoplasms: a competing risk analysis	68
Hypophosphataemia following ferric derisomaltose and ferric carboxymaltose in patients with iron deficiency anaemia due to inflammatory bowel disease (PHOSPHARE-IBD): a randomised clinical trial	68
Postprandial symptoms in disorders of gut-brain interaction and their potential as a treatment target	67
Enolase represents a metabolic checkpoint controlling the differential exhaustion programmes of hepatitis virus-specific CD8⁺T cells	67
Targeting MS4A4A on tumour-associated macrophages restores CD8+ T-cell-mediated antitumour immunity	67
Immunopathogenesis and environmental triggers in coeliac disease	66
Response letter to the editor	65
FSTL1 promotes liver fibrosis by reprogramming macrophage function through modulating the intracellular function of PKM2	65
GI highlights from the literature	64
GI highlights from the literature	64
A black liver	63
Fatal intestinal disease: a case of recurrent lower gastrointestinal bleeding	63
Submucosal steroid pre-injection strategy to prevent oesophageal stricture after circumferential endoscopic submucosal dissection	63
Nuclear Pirin promotes HCC by acting as a key inflammation-facilitating factor	63
Quest for HBV functional cure: what have we learnt from silencing RNAs?	62
Unravelling the obesity paradox in MASLD patients with extrahepatic cancer	62
Crosstalk between liver sinusoidal endothelial cells and hepatocytes via IL-1α–IL1R1 axis exacerbates ischaemia/reperfusion injury in aged livers	61
Non-invasive assessment of MASH resolution	61
Abnormal gastrointestinal motility is a major factor in explaining symptoms and a potential therapeutic target in patients with disorders of gut–brain interaction	61
NLRP6 deficiency enhances macrophage-mediated phagocytosis via E-Syt1 to inhibit hepatocellular carcinoma progression	60
Clinical relevance of biomarkers in cholangiocarcinoma: critical revision and future directions	59
Monocyte phenotypic liquid biopsy for NASH and liver fibrosis diagnosis: a new kid on the block	58
Prevalence of serum HBsAg <100 IU/mL in inactive chronic hepatitis B	57
Porcine-derived pancreatic enzyme replacement therapy may be linked to chronic hepatitis E virus infection in cystic fibrosis lung transplant recipients	57
It takes two to TAM-go	57
Gastric emptying study before gastric peroral endoscopic myotomy (G-POEM): can intragastric meal distribution be a predictor of success?	56
Comparison of drugs for active eosinophilic oesophagitis: systematic review and network meta-analysis	56
Molecular portraits of patients with intrahepatic cholangiocarcinoma who diverge as rapid progressors or long survivors on chemotherapy	56
National Institute for Health and Care Excellence (NICE) guidance on monitoring and management of Barrett’s oesophagus and stage I oesophageal adenocarcinoma	55
MED12 loss activates endogenous retroelements to sensitise immunotherapy in pancreatic cancer	55
Understanding the malignant potential of gastric metaplasia of the oesophagus and its relevance to Barrett’s oesophagus surveillance: individual-level data analysis	54
Spatial dissection of tumour microenvironments in gastric cancers reveals the immunosuppressive crosstalk between CCL2+ fibroblasts and STAT3-activated macrophages	54
GI highlights from the literature	53
NFATc1 signaling drives chronic ER stress responses to promote NAFLD progression	53
Correction:PMO-29 Switching between infliximab biosimilars: experience from two inflammatory bowel disease centres	53
Response by Abrahami et al to letter regarding article ‘Proton pump inhibitors and risk of colorectal cancer’	53
Withdrawal of antitumour necrosis factor in patients with inflammatory bowel disease in remission: a randomised placebo-controlled clinical trial of GETECCU	52
ISG15–CREB1 ISGylation: a stellate cell brake in liver fibrosis	52
Risk of metachronous advanced neoplasia in patients with serrated lesions depending on follow-up schedule	52
IL-20 subfamily cytokines impair the oesophageal epithelial barrier by diminishing filaggrin in eosinophilic oesophagitis	51
Correction: Fatty acids promote fatty liver disease via the dysregulation of 3-mercaptopyruvate sulfurtransferase/hydrogen sulfide pathway	50
Targeting ER protein TXNDC5 in hepatic stellate cell mitigates liver fibrosis by repressing non-canonical TGFβ signalling	49
Gut microbiota as non-invasive diagnostic and prognostic biomarkers for natural killer/T-cell lymphoma	49
Human milk oligosaccharide 2�-fucosyllactose protects against high-fat diet-induced obesity by changing intestinal mucus production, composition and degradation linked to changes in gut microbiota and	48
Cultivated human intestinal fungusCandida metapsilosisM2006B attenuates colitis by secreting acyclic sesquiterpenoids as FXR agonists	48
Global prevalence of non-alcoholic fatty liver disease in type 2 diabetes mellitus: an updated systematic review and meta-analysis	48
Assessment of the yearly carbon emission of a gastrointestinal endoscopy unit	47
NNMT enriches for AQP5⁺cancer stem cells to drive malignant progression in early gastric cardia adenocarcinoma	47
Interplay between diet, circulating indolepropionate concentrations and cardiometabolic health in US populations	47
Targeting TL1A and DR3: the new frontier of anti-cytokine therapy in IBD	47
Dominant-negative effect of lactase missense variants: hetero-complex assembly with the wild-type enzyme impairs intracellular trafficking and digestive function	46
Long-term use of proton pump inhibitors (PPIs) is associated with an increased risk of type 2 diabetes	45
Diagnostic dilemma: a patient with diarrhoea	45
Evaluation of proton pump inhibitors and risks of gastric cancer	44
Hepatic TM6SF2 activates antitumour immunity to suppress metabolic dysfunction-associated steatotic liver disease-related hepatocellular carcinoma and boosts immunotherapy	44
Pericyte drives the formation of circulating tumour cell-neutrophil clusters to promote colorectal cancer metastasis	44
APC and P53 mutations synergise to create a therapeutic vulnerability to NOTUM inhibition in advanced colorectal cancer	44
Fungi and cancer	44
Long-term hepatitis B surface antigen response after finite treatment of ARC-520 or JNJ-3989	43
Autologous T cell responses to primary human colorectal cancer spheroids are enhanced by ectonucleotidase inhibition	43
Lysosomal lipid switch sensitises to nutrient deprivation and mTOR targeting in pancreatic cancer	43
Human enteric nervous system progenitor transplantation improves functional responses in Hirschsprung disease patient-derived tissue	42
Landscape of the gut mycobiome dynamics during pregnancy and its relationship with host metabolism and pregnancy health	42
Prevalence of irritable bowel syndrome and functional dyspepsia after acute gastroenteritis: systematic review and meta-analysis	42
The Peptidoglycan Recognition Protein 1 confers immune evasive properties on pancreatic cancer stem cells	42
Synergistic association of sodium-glucose cotransporter-2 inhibitor and metformin on liver and non-liver complications in patients with type 2 diabetes mellitus and metabolic dysfunction-associated st	42
Targeting MYC effector functions in pancreatic cancer by inhibiting the ATPase RUVBL1/2	41
The road to a world-unified approach to the management of patients with gastric intestinal metaplasia: a review of current guidelines	40
Combining epigenetic modulation: the next step for HCC immunotherapy?	40

Correction:O4 Acceptability and feasibility of a multimodal early detection pilot study for liver disease in high risk groups: “Alright My Liver?”	40
Correction:Sympathetic nervous activation, mitochondrial dysfunction and outcome in acutely decompensated cirrhosis: the metabolomic prognostic models (CLIF-C MET)	39
GI highlights from the literature	39
Tailoring treatment to the circumstance: reasoning behind metal versus plastic drainage of pancreatic collections	39
Is the significant risk of perioperative complications associated with radical surgery following non-curative endoscopic submucosal dissection for early colorectal cancer still acceptable?	39
Is HBx protein the X factor in the pathogenesis of IBD?	39
GI snapshot: arrhythmia, dysphagia and weight loss in a 71-year-old man	39
Correction: Macrophages direct cancer cells through a LOXL2-mediated metastatic cascade in pancreatic ductal adenocarcinoma	38
Basal levels of microbiota-driven subclinical inflammation are associated with anastomotic leak in patients with colorectal cancer	38
Sex-based differences in prescribed medications, surgical procedures and disease-related complications in IBD	38
Hereditary diffuse gastric cancer spectrum associated with germline CTNNA1 loss of function revealed by clinical and molecular data from 351 carrier families and over 37 000 non-carrier control	37
DYRK1B blockade promotes tumoricidal macrophage activity in pancreatic cancer	37
Establishment of a validated central reading system for ileocolonoscopy in an academic setting	37
Rise of precision medicine: can it deliver on its promise in IBD?	37
Specific gut pathobionts escape antibody coating and are enriched during flares in patients with severe Crohn’s disease	36
Variceal band ligation and carvedilol: together forever, or not?	36
Trends and cross-country inequality in the incidence of GI cancers among the working-age population from 1990 to 2021: a Global Burden of Disease 2021 analysis	36
Simplified Helicobacter pylori therapy for patients with penicillin allergy: a randomised controlled trial of vonoprazan-tetracycline dual therapy	36
Endocytoscopy with automated multispectral intestinal barrier pathology imaging for assessment of deep healing to predict outcomes in ulcerative colitis	35
Precancerous nature of intestinal metaplasia with increased chance of conversion and accelerated DNA methylation	35
Alcohol exhibits contrasting effects on CD8 ⁺ T cells in the gut and liver in alcohol-associated liver disease	35
SARS-CoV-2 Omicron variant infection was associated with higher morbidity in patients with cirrhosis	34
PDE5A⁺ cancer-associated fibroblasts enhance immune suppression in gastric cancer	34
Liver stiffness thresholds to predict disease progression and clinical outcomes in bridging fibrosis and cirrhosis	34
Eosinophils: a novel therapeutic target to promote liver regeneration in acute liver injury?	34
Alterations to the duodenal microbiota are linked to gastric emptying and symptoms in functional dyspepsia	34
Single-cell omics in inflammatory bowel disease: recent insights and future clinical applications	33
Maternal antibiotic exposure during pregnancy and risk of IBD in offspring: a population-based cohort study	33
Cellular immunotherapies and immune cell depleting therapies in inflammatory bowel diseases: the next magic bullet?	33
Estimating the environmental impact of disposable endoscopic equipment and endoscopes	33
Vessel and tissue recognition during third-space endoscopy using a deep learning algorithm	33
Artificial intelligence applied to ‘omics data in liver disease: towards a personalised approach for diagnosis, prognosis and treatment	33
Phenotypic CD8 T cell profiling in chronic hepatitis B to predict HBV-specific CD8 T cell susceptibility to functional restoration in vitro	33
Antibody response to the BNT162b2 SARS-CoV-2 vaccine in paediatric patients with inflammatory bowel disease treated with anti-TNF therapy	33
Gut microbiome and dietary fibre intake strongly associate with IgG function and maturation following SARS-CoV-2 mRNA vaccination	32
Nuclear translocation of plasma membrane protein ADCY7 potentiates T cell-mediated antitumour immunity in HCC	32
Recent advances in incretin-based therapy for MASLD: from single to dual or triple incretin receptor agonists	31
Combining ferroptosis induction with MDSC blockade renders primary tumours and metastases in liver sensitive to immune checkpoint blockade	31
Unusual cause of abdominal pain	31
Organoids in gastrointestinal diseases: from experimental models to clinical translation	31
Cold versus hot snare endoscopic mucosal resection for large (≥15 mm) flat non-pedunculated colorectal polyps: a randomised controlled trial	31
Reply to Newmanet al‘Response to epidemiology of inflammatory bowel disease in men with high-risk homosexual activity’	31
Ferritin—a promising biomarker in MASLD	31
Effectiveness of mailed outreach and patient navigation to promote HCC screening process completion: a multicentre pragmatic randomised clinical trial	31
HBV integrations reshaping genomic structures promote hepatocellular carcinoma	31
CAF-macrophage crosstalk in tumour microenvironments governs the response to immune checkpoint blockade in gastric cancer peritoneal metastases	31
British Society of Gastroenterology guidelines for the diagnosis and management of cholangiocarcinoma	31
Germline mutations and pancreatic cancer risk in chronic pancreatitis	30
Is the biogeography of the mucosa-associated microbiota a key factor affecting primary sclerosing cholangitis disease course and treatment?	30
Reconsidering statins in MASLD: beyond cardiovascular protection to multisystem benefit	30
Performance of the China-CLIF framework in acute-on-chronic liver failure: a multicohort study across all aetiologies	30
eCura and W-eCura: different scores, different populations, same goal	30
Response to: ‘Differentiating gastroparesis from functional dyspepsia is no longer sufficient’ by O’Grady et al	29
Correction:O11 Utilising peer support workers in hepatitis C screening in emergency departments: a pilot study	29
Purified oat protein can trigger acute symptoms linked to immune activation in coeliac disease patients but not histological deterioration	29
Toxic microbiome and progression of chronic kidney disease: insights from a longitudinal CKD-microbiome study	29
More than meets the eye: a strange cause of bowel obstruction and perforation	29
Smoking affects gut immune system of patients with inflammatory bowel diseases by modulating metabolomic profiles and mucosal microbiota	29
Presenilins: the hidden guardians of gut health in Alzheimer’s disease	29
Porcine-derived pancreatic enzyme replacement therapy: a cause of hepatitis E virus transmission?	28
Mapping the human gut mycobiome in middle-aged and elderly adults: multiomics insights and implications for host metabolic health	28
Intravital imaging: dynamic insights into liver immunity in health and disease	28
Accuracy of measuring colorectal polyp size in pathology: a prospective study	28
Genetic and transcriptomic landscape of colonic diverticulosis	28
Clinical outcome of non-curative endoscopic submucosal dissection for early colorectal cancer	27
Gnotobiotic mice housing conditions critically influence the phenotype associated with transfer of faecal microbiota in a context of obesity	27
Response to ‘Biliary sludge and microlithiasis: are we covering the full spectrum of lithogenic biliary disorders?’	27
Efficacy of biological therapies and small molecules in moderate to severe ulcerative colitis: systematic review and network meta-analysis	27
Key metabolomic alterations are associated with ulcerative colitis disease state and activity: a validation analysis	27
Correction: British Society of Gastroenterology guidelines on inflammatory bowel disease in adults: 2025	27
CRIP1 fosters MDSC trafficking and resets tumour microenvironment via facilitating NF-κB/p65 nuclear translocation in pancreatic ductal adenocarcinoma	27
Inhibition of YTHDF1 by salvianolic acid overcomes gluten-induced intestinal inflammation	27
An unusual cause of oesophageal stricture	27
Congenital sucrase-isomaltase mutations worsen IBS-linked V15F dysfunction and trafficking	26
Cutting waste in endoscopy: the roles of professional practice and staffing levels	26
Omega-3 polyunsaturated fatty acids: moving towards precision use for prevention and treatment of colorectal cancer	26
Purastat post-EMR: unresolved questions from the PURPLE trial	26
Patient-reported experience of colonoscopy in Italy: a multicentre prospective observational study	26
Post-acute COVID-19 syndrome and gut dysbiosis linger beyond 1 year after SARS-CoV-2 clearance	26
Correction:Residual SARS-CoV-2 viral antigens detected in GI and hepatic tissues from five recovered patients with COVID-19	26
Stressed hepatocyte sustains alcohol-associated hepatitis progression by producing leukocyte cell-derived chemotaxin 2	26
DNA-methylation signature accurately differentiates pancreatic cancer from chronic pancreatitis in tissue and plasma	26
Response to the letter to the editor ‘revisiting lipid dysregulation in colorectal cancer: critical appraisal of pro-inflammatory bias and therapeutic implications’	26
MAFLD, HCC and the dilemma of (changing) terminology in liver diseases	25
Over-the-scope-clips versus standard treatment in high-risk patients with acute non-variceal upper gastrointestinal bleeding: a randomised controlled trial (STING-2)	25
Faecal immunochemical testing (FIT) in patients with signs or symptoms of suspected colorectal cancer (CRC): a joint guideline from the Association of Coloproctology of Great Britain and Ireland (ACPG	25
Response to: Correspondence on "PICaSSO Histologic Remission Index (PHRI) in ulcerative colitis: development of a novel simplified histological score for monitoring mucosal healing and predicting clin	25
Cold versus hot EMR for large duodenal adenomas	25
Global prevalence of self-reported non-coeliac gluten and wheat sensitivity: a systematic review and meta-analysis	25
Adherent-invasive Escherichia coli in Crohn’s disease: the 25th anniversary	25
Correction:Growth differentiation factor 11 attenuates liver fibrosis via expansion of liver progenitor cells	25
Patient selection for urgent endoscopic retrograde cholangio-pancreatography by endoscopic ultrasound in predicted severe acute biliary pancreatitis (APEC-2): a multicentre prospective study	25
Long-term liver-related outcomes and liver stiffness progression of statin usage in steatotic liver disease	25
Short-chain fatty acids in patients with severe acute pancreatitis: friend or foe?	25
Correspondence to proton pump inhibitors and risk of colorectal cancer	24